BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ragusa F, Ferrari SM, Elia G, Paparo SR, Balestri E, Botrini C, Patrizio A, Mazzi V, Guglielmi G, Foddis R, Spinelli C, Ulisse S, Antonelli A, Fallahi P. Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer. Int J Mol Sci 2022;23:5731. [PMID: 35628540 DOI: 10.3390/ijms23105731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ulisse S, Baldini E, Pironi D, Gagliardi F, Tripodi D, Lauro A, Carbotta S, Tarroni D, D'Armiento M, Morrone A, Forte F, Frattaroli F, Persechino S, Odorisio T, D'Andrea V, Lori E, Sorrenti S. Is Melanoma Progression Affected by Thyroid Diseases? Int J Mol Sci 2022;23:10036. [PMID: 36077430 DOI: 10.3390/ijms231710036] [Reference Citation Analysis]
2 Horgan D, Führer-sakel D, Soares P, Alvarez CV, Fugazzola L, Netea-maier RT, Jarzab B, Kozaric M, Bartes B, Schuster-bruce J, Dal Maso L, Schlumberger M, Pacini F. Tackling Thyroid Cancer in Europe—The Challenges and Opportunities. Healthcare 2022;10:1621. [DOI: 10.3390/healthcare10091621] [Reference Citation Analysis]
3 Allen KJH, Malo ME, Jiao R, Dadachova E. Targeting Melanin in Melanoma with Radionuclide Therapy. IJMS 2022;23:9520. [DOI: 10.3390/ijms23179520] [Reference Citation Analysis]